Paclitaxel-bevacizumab in Advanced Lung Cancer

Clinical trial NCT01763671 · COMPLETED

Trial details

NCT number: NCT01763671
Sponsor: Intergroupe Francophone de Cancerologie Thoracique
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-squamous Non-small Cell Lung Cancer

Start date: 2013-05-01
Primary completion: 2015-12-01
Enrollment: 166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.